Advertisement

AIDS and Behavior

, Volume 20, Issue 4, pp 710–716 | Cite as

Antiretroviral Treatment and Sexual Risk Behavior in South Africa

  • Kathryn Risher
  • Thomas Rehle
  • Leickness Simbayi
  • Olive Shisana
  • David D. Celentano
Original Paper

Abstract

The sexual behavior of individuals living with HIV determines the onward transmission of HIV. With the understanding that antiretroviral therapy (ART) prevents transmission of HIV, the sexual behaviors of the individuals not on ART with unsuppressed viral loads becomes of the greatest importance in elucidating transmission. We assessed the association between being on ART and sexual risk behavior among those living with HIV in a nationally representative population-based cross-sectional survey of households in South Africa that was conducted in 2012. Of 2237 adults (aged 15–49) who tested HIV-seropositive, 667 (29.8 %) had detectable antiretroviral drugs in their blood specimens. Among males, 77.7 % of those on ART reported having had sex in the past year contrasted with 88.4 % of those not on ART (p = 0.001); among females, 72.2 % of those on ART reported having had sex in the past year while 80.3 % of those not on ART did (p < 0.001). For males and females, the odds of reporting consistent condom use and condom use at last sex were statistically significantly higher for individuals on ART compared to those not on ART (males: consistent condom use aOR 2.8, 95 % CI 1.6–4.9, condom use at last sex aOR 2.6, 95 % CI 1.5–4.6; females: consistent condom use aOR 2.3, 95 % CI 1.7–3.1, condom use at last sex aOR 2.3, 95 % CI 1.7–3.1), while there were no statistically significant differences in odds of reporting multiple sexual partners in the past year. In this nationally representative population-based survey of South African adults, we found evidence of less risky sexual risk behavior among people living with HIV on ART compared to those not on ART.

Keywords

Antiretroviral therapy People living with HIV South Africa Sexual behavior 

Notes

Acknowledgments

This article has been supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of 3U2GGH000570. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC. We also acknowledge the John Hopkins University Center for AIDS Research (1P30AI094189) and the National Institutes of Health (T32AI102623).

References

  1. 1.
    Shisana O, Rehle T, Simbayi L, et al. South African National HIV Prevalence, Incidence and Behaviour Survey, 2012. Cape Town: HSRC Press; 2014.Google Scholar
  2. 2.
    Abdool Karim SS, Abdool Karim Q, Gouws E, Baxter C. Global epidemiology of HIV-AIDS. Infect Dis Clin North Am. 2007;21(1):1–17.CrossRefPubMedGoogle Scholar
  3. 3.
    South African National AIDS Council. Republic of South Africa Global AIDS Response Progress Report 2013. http://sanac.org.za/publications/reports/doc_download/61-ungass-south-africa-report. Accessed 2 Aug 2014.
  4. 4.
    Department of Health Republic of South Africa. South African Antiretroviral Treatment Guidelines 2013. ART Treatment Guidelines Final 25 March 2013 corrected.pdf. http://www.sahivsoc.org/upload/documents/2013 Accessed 2 Aug 2014.
  5. 5.
    Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Wamoyi J, Mbonye M, Seeley J, Birungi J, Jaffar S. Changes in sexual desires and behaviours of people living with HIV after initiation of ART: implications for HIV prevention and health promotion. BMC Public Health. 2011;11:633.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Redd AD, Quinn TC, Tobian AA. Frequency and implications of HIV superinfection. Lancet Infect Dis. 2013;13(7):622–8.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    World Health Organization HIV/AIDS Programme. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach 2013. http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf. Accessed 1 Aug 2013.
  9. 9.
    Peltzer K, Friend-du Preez N, Ramlagan S, Anderson J. Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa. BMC Public Health. 2010;10:111.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Maqutu D, Zewotir T, North D, Naidoo K, Grobler A. Determinants of optimal adherence over time to antiretroviral therapy amongst HIV positive adults in South Africa: a longitudinal study. AIDS Behav. 2011;15(7):1465–74.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Stolte IG, Dukers NH, Geskus RB, Coutinho RA, de Wit JB. Homosexual men change to risky sex when perceiving less threat of HIV/AIDS since availability of highly active antiretroviral therapy: a longitudinal study. AIDS. 2004;18(2):303–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Dukers NH, Goudsmit J, de Wit JB, Prins M, Weverling GJ, Coutinho RA. Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS. 2001;15(3):369–78.CrossRefPubMedGoogle Scholar
  13. 13.
    Ostrow DE, Fox KJ, Chmiel JS, et al. Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS. 2002;16(5):775–80.CrossRefPubMedGoogle Scholar
  14. 14.
    Tun W, Gange SJ, Vlahov D, Strathdee SA, Celentano DD. Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. Clin Infect Dis. 2004;38(8):1167–74.CrossRefPubMedGoogle Scholar
  15. 15.
    Eisele TP, Mathews C, Chopra M, et al. High levels of risk behavior among people living with HIV Initiating and waiting to start antiretroviral therapy in Cape Town South Africa. AIDS Behav. 2008;12(4):570–7.CrossRefPubMedGoogle Scholar
  16. 16.
    Peltzer K, Ramlagan S. Safer sexual behaviours after 1 year of antiretroviral treatment in KwaZulu-Natal, South Africa: a prospective cohort study. Sex Health. 2010;7(2):135–41.CrossRefPubMedGoogle Scholar
  17. 17.
    Venkatesh KK, de Bruyn G, Lurie MN, et al. Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics. AIDS. 2010;24(17):2687–96.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Eisele TP, Mathews C, Chopra M, et al. Changes in risk behavior among HIV-positive patients during their first year of antiretroviral therapy in Cape Town South Africa. AIDS Behav. 2009;13(6):1097–105.CrossRefPubMedGoogle Scholar
  19. 19.
    Apondi R, Bunnell R, Ekwaru JP, et al. Sexual behavior and HIV transmission risk of Ugandan adults taking antiretroviral therapy: 3 year follow-up. AIDS. 2011;25(10):1317–27.CrossRefPubMedGoogle Scholar
  20. 20.
    Dia A, Marcellin F, Bonono RC, et al. Prevalence of unsafe sex with one’s steady partner either HIV-negative or of unknown HIV status and associated determinants in Cameroon (EVAL ANRS12-116 survey). Sex Transm Infect. 2010;86(2):148–54.CrossRefPubMedGoogle Scholar
  21. 21.
    Bateganya M, Colfax G, Shafer LA, et al. Antiretroviral therapy and sexual behavior: a comparative study between antiretroviral- naive and -experienced patients at an urban HIV/AIDS care and research center in Kampala, Uganda. AIDS Patient Care STDS. 2005;19(11):760–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Moatti JP, Prudhomme J, Traore DC, et al. Access to antiretroviral treatment and sexual behaviours of HIV-infected patients aware of their serostatus in Cote d’Ivoire. AIDS. 2003;17(Suppl 3):S69–77.CrossRefPubMedGoogle Scholar
  23. 23.
    Luchters S, Sarna A, Geibel S, et al. Safer sexual behaviors after 12 months of antiretroviral treatment in Mombasa, Kenya: a prospective cohort. AIDS Patient Care STDS. 2008;22(7):587–94.CrossRefPubMedGoogle Scholar
  24. 24.
    Wandera B, Kamya MR, Castelnuovo B, et al. Sexual behaviors over a 3-year period among individuals with advanced HIV/AIDS receiving antiretroviral therapy in an urban HIV clinic in Kampala, Uganda. J Acquir Immune Defic Syndr. 2011;57(1):62–8.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Thirumurthy H, Goldstein M, Zivin JG, Habyarimana J, Pop-Eleches C. Behavioral responses of patients in AIDS treatment programs: sexual behavior in Kenya. Forum Health Econ Policy. 2012;15(2):1–29.CrossRefGoogle Scholar
  26. 26.
    Yalew E, Zegeye DT, Meseret S. Patterns of condom use and associated factors among adult HIV positive clients in North Western Ethiopia: a comparative cross sectional study. BMC Public Health. 2012;12:308.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Bunnell R, Ekwaru JP, Solberg P, et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS. 2006;20(1):85–92.CrossRefPubMedGoogle Scholar
  28. 28.
    Berhan A, Berhan Y. Is the sexual behaviour of HIV patients on antiretroviral therapy safe or risky in sub-Saharan Africa? Meta-analysis and meta-regression. AIDS Res Ther. 2012;9(1):14.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Olley BO. Higher-risk sexual behaviour among HIV patients receiving antiretroviral treatment in Ibadan, Nigeria. Afr J AIDS Res. 2008;7(1):71–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Shafer LA, Nsubuga RN, White R, et al. Antiretroviral therapy and sexual behavior in Uganda: a cohort study. AIDS. 2011;25(5):671–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Pearson CR, Cassels S, Kurth AE, Montoya P, Micek MA, Gloyd SS. Change in sexual activity 12 months after ART initiation among HIV-positive Mozambicans. AIDS Behav. 2011;15(4):778–87.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Statistics South Africa. Census 2011 South Africa 2012. http://www.statssa.gov.za/Publications/P03014/P030142011.pdf. Accessed 2 Aug 2014.
  33. 33.
    Fishel J, Barrere B, Kishor S. Validity of data on self-reported HIV status and implications for measurement of ARV coverage in Malawi. DHS Working Papers No. 81. Calverton: ICF International; 2012.Google Scholar
  34. 34.
    Fogel JM, Wang L, Parsons TL, et al. Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052). J Infect Dis. 2013;208(10):1624–8.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Dokubo EK, Shiraishi RW, Young PW, et al. Awareness of HIV status, prevention knowledge and condom use among people living with HIV in Mozambique. PLoS ONE. 2014;9(9):e106760.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Rosenberg NE, Pettifor AE, De Bruyn G, et al. HIV testing and counseling leads to immediate consistent condom use among South African stable HIV-discordant couples. J Acquir Immune Defic Syndr. 2013;62(2):226–33.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Bunnell R, Opio A, Musinguzi J, et al. HIV transmission risk behavior among HIV-infected adults in Uganda: results of a nationally representative survey. AIDS. 2008;22(5):617–24.CrossRefPubMedGoogle Scholar
  38. 38.
    Cassell MM, Halperin DT, Shelton JD, Stanton D. Risk compensation: the Achilles’ heel of innovations in HIV prevention? BMJ. 2006;332(7541):605–7.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Venkatesh KK, Flanigan TP, Mayer KH. Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world. AIDS. 2011;25(16):1939–49.CrossRefPubMedGoogle Scholar
  40. 40.
    Clark S, Kabiru C, Zulu E. Do men and women report their sexual partnerships differently? Evidence from Kisumu, Kenya. Int Perspect Sex Reprod Health. 2011;37(4):181–90.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Kathryn Risher
    • 1
  • Thomas Rehle
    • 2
    • 3
  • Leickness Simbayi
    • 2
    • 4
  • Olive Shisana
    • 2
    • 4
  • David D. Celentano
    • 1
  1. 1.Department of EpidemiologyJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA
  2. 2.Human Sciences Research CouncilCape TownSouth Africa
  3. 3.School of Public Health and Family MedicineUniversity of Cape TownCape TownSouth Africa
  4. 4.Department of Psychiatry and Mental HealthUniversity of Cape TownCape TownSouth Africa

Personalised recommendations